Literature DB >> 16530785

Acetaminophen attenuates peroxynitrite-activated matrix metalloproteinase-2-mediated troponin I cleavage in the isolated guinea pig myocardium.

Tyler H Rork1, Norell M Hadzimichalis, Maya A Kappil, Gary F Merrill.   

Abstract

The peroxynitrite-mediated activation of matrix metalloproteinase-2 (MMP-2) and subsequent cleavage of troponin I (TnI) in ventricular myocytes is a detrimental effect of ischemia/reperfusion injury. We hypothesized that acetaminophen, an effective antioxidant against peroxynitrite, would attenuate activation of MMP-2 and improve cardiac mechanical function. Isolated, perfused guinea pig hearts (Langendorff) were treated with either acetaminophen [0.35 mmol/l] or its vehicle and administered a bolus injection of peroxynitrite (6 microM) after reaching steady state function. Hemodynamic, metabolic, and mechanical effects were recorded, and coronary effluent concentrates or supernatant from heart homogenates were subjected to Western blotting and gelatin zymography. Hemodynamic and metabolic data showed no difference between acetaminophen- and vehicle-treated hearts. Mechanical data revealed that treatment with acetaminophen preserved contractile function (particularly diastolic function) after peroxynitrite administration. For example, 5 min after administration of peroxynitrite percent baseline -dP/dt(max) was 10+/-3% and -4+/-7% (P<0.05) in acetaminophen- and vehicle-treated hearts, respectively. Western blotting and gel zymography revealed higher 72 kDa (pro-MMP-2) proteolytic activity in heart homogenates of vehicle-treated versus acetaminophen-treated hearts. In addition, Western blotting of heart homogenates showed increased degradative products of TnI in vehicle-treated versus acetaminophen-treated hearts. We conclude that acetaminophen is cardioprotective, at least in part, by attenuating peroxynitrite-activated, MMP-2-mediated cleavage of TnI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530785     DOI: 10.1016/j.yjmcc.2006.01.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  14 in total

1.  Biphasic effect of SIN-1 is reliant upon cardiomyocyte contractile state.

Authors:  Mark J Kohr; Honglan Wang; Debra G Wheeler; Murugesan Velayutham; Jay L Zweier; Mark T Ziolo
Journal:  Free Radic Biol Med       Date:  2008-04-04       Impact factor: 7.376

2.  Loss of dystrophin is associated with increased myocardial stiffness in a model of left ventricular hypertrophy.

Authors:  Martín Donato; Bruno Buchholz; Celina Morales; Laura Valdez; Tamara Zaobornyj; Sergio Baratta; Diamela T Paez; Mirian Matoso; Guillermo Vaccarino; Demian Chejtman; Oscar Agüero; Juan Telayna; José Navia; Alejandro Hita; Alberto Boveris; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2017-03-18       Impact factor: 3.396

Review 3.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 4.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

5.  Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte.

Authors:  H León; I Baczkó; G Sawicki; P E Light; R Schulz
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

6.  Targeting of phospholamban by peroxynitrite decreases beta-adrenergic stimulation in cardiomyocytes.

Authors:  Mark J Kohr; Honglan Wang; Debra G Wheeler; Murugesan Velayutham; Jay L Zweier; Mark T Ziolo
Journal:  Cardiovasc Res       Date:  2007-09-19       Impact factor: 10.787

7.  Pyruvate enhances neurological recovery following cardiopulmonary arrest and resuscitation.

Authors:  Arti B Sharma; Matthew A Barlow; Shao-Hua Yang; James W Simpkins; Robert T Mallet
Journal:  Resuscitation       Date:  2007-07-06       Impact factor: 5.262

8.  Effects of novel semiselective matrix metalloproteinase inhibitors on ex vivo cardiac structure-function.

Authors:  Diego Romero-Perez; Arpita Agrawal; Jennifer Jacobsen; Yilong Yan; Robert Thomas; Seth Cohen; Francisco Villarreal
Journal:  J Cardiovasc Pharmacol       Date:  2009-06       Impact factor: 3.105

9.  Ischemic postconditioning: mechanisms, comorbidities, and clinical application.

Authors:  Bruno Buchholz; Martín Donato; Verónica D'Annunzio; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2014-03-13       Impact factor: 3.396

10.  Experimentally-induced ventricular arrhythmias.

Authors:  Gary F Merrill
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.